Skip to main navigation Skip to search Skip to main content

STOMP: Small Cell Lung Cancer Trial of Olaparib (AZD2281) as Maintenance Programme: a randomised, double blind, multicentre phase II trial

Project Details

Short titleSTOMP: Small Cell Lung Cancer Trial of Olaparib (AZD2281) as Maintenance Programme: a randomised, double blind, multicentre phase II trial
StatusActive
Effective start/end date1/07/11 → 30/06/27

Funding

  • Astra Zeneca Uk Limited